Leerink Partners Upgrades Halozyme Therapeutics (HALO) to Market Perform
Go back to Leerink Partners Upgrades Halozyme Therapeutics (HALO) to Market Perform| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 100.62 -0.05 (0.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $100.67 | 52 Week High | $18.39 | |||
| Open | $100.35 | 52 Week Low | $6.96 | |||
| Day High | $100.83 | P/E | N/A | |||
| Day Low | $99.56 | EPS | $-0.58 | |||
| Volume | 58,230 | |||||
